去年，Perrigo Company PLC表现最佳的业务板块Contract Manufacturing实现营收270.90M美元。United States的营收贡献最高，去年达到2.54B美元。最近一个季度，截至2025-12-31，Perrigo Company PLC表现最佳的业务板块Upper respiratory实现营收217.80M美元。United States的营收贡献最高，达到626.40M美元。

业务

营业收入

占比

年报

年报

单季报

Contract Manufacturing

Upper respiratory

Pain and sleep-aids

Skincare and personal hygiene

Nutrition

Digestive health

Healthy lifestyle

Oral self-care

Vitamins, minerals, and supplements

Other

Women's Health

Animal health

Unallocated

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

Contract Manufacturing

270.90M(100.00%)

306.20M(100.00%)

--(--)

262.40M(6.03%)

286.80M(6.90%)

300.50M(100.00%)

Upper respiratory

--(--)

858.30M(18.44%)

823.20M(18.49%)

709.30M(17.14%)

760.90M(17.49%)

806.10M(19.39%)

--(--)

Pain and sleep-aids

--(--)

619.30M(13.30%)

595.20M(13.37%)

607.20M(14.67%)

624.90M(14.36%)

558.80M(13.44%)

--(--)

Skincare and personal hygiene

--(--)

568.70M(12.22%)

620.00M(13.93%)

613.50M(14.82%)

552.40M(12.70%)

562.90M(13.54%)

--(--)

Nutrition

--(--)

563.20M(12.10%)

520.40M(11.69%)

401.90M(9.71%)

388.30M(8.93%)

395.30M(9.51%)

--(--)

Digestive health

--(--)

546.30M(11.73%)

517.00M(11.61%)

513.50M(12.41%)

497.80M(11.44%)

456.30M(10.98%)

--(--)

Healthy lifestyle

--(--)

537.40M(11.54%)

425.30M(9.55%)

477.00M(11.53%)

517.80M(11.90%)

529.90M(12.75%)

--(--)

Oral self-care

--(--)

415.40M(8.92%)

401.50M(9.02%)

407.70M(9.85%)

386.00M(8.87%)

162.90M(3.92%)

--(--)

Vitamins, minerals, and supplements

--(--)

203.00M(4.36%)

219.70M(4.94%)

249.10M(6.02%)

228.00M(5.24%)

208.80M(5.02%)

--(--)

Other

--(--)

177.40M(3.81%)

184.90M(4.15%)

159.50M(3.85%)

132.10M(3.04%)

145.20M(3.49%)

--(--)

Women's Health

--(--)

166.60M(3.58%)

144.20M(3.24%)

--(--)

Animal health

--(--)

43.70M(1.05%)

--(--)

Unallocated

--(--)

地区

营业收入

占比

年报

年报

单季报

United States

Europe

All other countries

Ireland

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

FY2015

FY2014

FY2013

United States

2.54B(59.72%)

2.65B(60.58%)

2.92B(62.65%)

2.87B(64.47%)

2.57B(62.00%)

2.58B(63.08%)

2.36B(60.99%)

3.10B(65.48%)

3.27B(66.16%)

3.35B(63.50%)

3.30B(71.76%)

3.29B(81.06%)

2.87B(91.10%)

Europe

1.62B(38.00%)

1.60B(36.69%)

1.62B(34.85%)

1.47B(33.12%)

1.39B(33.66%)

1.35B(33.04%)

1.34B(34.52%)

1.35B(28.48%)

1.31B(26.55%)

1.49B(28.27%)

613.60M(13.33%)

--(--)

All other countries

96.70M(2.27%)

119.50M(2.73%)

116.30M(2.50%)

107.30M(2.41%)

179.80M(4.34%)

158.60M(3.88%)

173.80M(4.49%)

285.80M(6.04%)

330.30M(6.68%)

345.50M(6.54%)

342.70M(7.44%)

622.50M(15.33%)

279.40M(8.87%)

Ireland

--(--)

30.40M(0.61%)

89.10M(1.69%)

344.00M(7.47%)

146.70M(3.61%)

1.00M(0.03%)